BIOMAT Database Logo BIOMAT Database Logo

New antitumor antibiotics, FR-900405 and FR-900406. II. Production, isolation, characterization and antitumor activity. 1985

S Kiyoto, and M Nishikawa, and H Terano, and M Kohsaka, and H Aoki, and H Imanaka, and Y Kawai, and I Uchida, and M Hashimoto

The new antitumor antibiotics, FR-900405 and FR-900406, were isolated from the culture broth of Actinomadura pulveracea sp. nov. No. 6049. These compounds which contain sulfur in the molecule, represent a novel class of antitumor agents. FR-900405 and FR-900406 are highly active in mice against experimental tumors and exhibit antimicrobial activity against Gram-positive and Gram-negative bacteria and fungi.

UI MeSH Term Description Entries
D008297 Male Males
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females
D000192 Actinomycetales An order of gram-positive, primarily aerobic BACTERIA that tend to form branching filaments. Corynebacteriaceae,Coryneform Group
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

S Kiyoto, and M Nishikawa, and H Terano, and M Kohsaka, and H Aoki, and H Imanaka, and Y Kawai, and I Uchida, and M Hashimoto
New antitumor antibiotic, FR-900462. II. Production, isolation, characterization and biological activity.
May 1989, The Journal of antibiotics,
S Kiyoto, and M Nishikawa, and H Terano, and M Kohsaka, and H Aoki, and H Imanaka, and Y Kawai, and I Uchida, and M Hashimoto
A new antitumor antibiotic, FR-900482. II. Production, isolation, characterization and biological activity.
May 1987, The Journal of antibiotics,
S Kiyoto, and M Nishikawa, and H Terano, and M Kohsaka, and H Aoki, and H Imanaka, and Y Kawai, and I Uchida, and M Hashimoto
A new antitumor antibiotic, chromoxymycin. II. Production, isolation, characterization and antitumor activity.
January 1986, The Journal of antibiotics,
S Kiyoto, and M Nishikawa, and H Terano, and M Kohsaka, and H Aoki, and H Imanaka, and Y Kawai, and I Uchida, and M Hashimoto
Tetrocarcins, novel antitumor antibiotics. II. Isolation, characterization and antitumor activity.
September 1980, The Journal of antibiotics,
S Kiyoto, and M Nishikawa, and H Terano, and M Kohsaka, and H Aoki, and H Imanaka, and Y Kawai, and I Uchida, and M Hashimoto
Elsamicins, new antitumor antibiotics related to chartreusin. I. Production, isolation, characterization and antitumor activity.
June 1986, The Journal of antibiotics,
S Kiyoto, and M Nishikawa, and H Terano, and M Kohsaka, and H Aoki, and H Imanaka, and Y Kawai, and I Uchida, and M Hashimoto
Macbecins I and II, new antitumor antibiotics. II. Isolation and characterization.
February 1980, The Journal of antibiotics,
S Kiyoto, and M Nishikawa, and H Terano, and M Kohsaka, and H Aoki, and H Imanaka, and Y Kawai, and I Uchida, and M Hashimoto
Studies on new phosphonic acid antibiotics. III. Isolation and characterization of FR-31564, FR-32863 and FR-33289.
January 1980, The Journal of antibiotics,
S Kiyoto, and M Nishikawa, and H Terano, and M Kohsaka, and H Aoki, and H Imanaka, and Y Kawai, and I Uchida, and M Hashimoto
BBM-928, a new antitumor antibiotic complex. I. Production, isolation, characterization and antitumor activity.
October 1980, The Journal of antibiotics,
S Kiyoto, and M Nishikawa, and H Terano, and M Kohsaka, and H Aoki, and H Imanaka, and Y Kawai, and I Uchida, and M Hashimoto
Studies on new phosphonic acid antibiotics. I. FR-900098, isolation and characterization.
January 1980, The Journal of antibiotics,
S Kiyoto, and M Nishikawa, and H Terano, and M Kohsaka, and H Aoki, and H Imanaka, and Y Kawai, and I Uchida, and M Hashimoto
Dnacins, new antibiotics II. Isolation and characterization.
December 1980, The Journal of antibiotics,
Copied contents to your clipboard!